Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with Type 1 diabetes, according to new research published in the iBMJ/i. Researchers looked at once-daily and twice-daily doses of both long- and intermediate-acting insulin, ranking their effectiveness, safety and cost-effectiveness. "In patients with Type 1 diabetes, we found that long-acting insulin is superior to intermediate-acting insulin when it ...
Read MoreYou have just read an article categorized health
titled Long-acting Insulin More Effective for Patients With Type 1 Diabetes.
Written by:
editor - Wednesday, October 1, 2014
There are currently no comments for "Long-acting Insulin More Effective for Patients With Type 1 Diabetes"
Post a Comment